Speech-based Alzheimer's disease (AD) detection increasingly relies on speech-enhanced and curated versions of the Pitt Corpus, where speech enhancement, sample selection, and demographic balancing ar...
The paper examines why speech‑based screening for Alzheimer’s disease fails to generalize across different languages, tasks, and recording protocols. Using a leave‑one‑corpus‑out evaluation on four datasets, it finds that 59 of 70 interpretable speech features show conflicting patterns between healthy controls and cognitive risk groups, with pause, silence, and speech rate being highly protocol‑sensitive. The authors propose a fusion method that combines XLM‑R text baseline scores with evidence anchors, improving mean speaker AUC to 0.785 and worst‑case AUC to 0.615, and emphasize the importance of auditing feature transferability and reporting worst‑case domain robustness.
By Zijian Lu, Sizhe Liu, Yin Zhang, Jixuan Deng, Xinrong Lin, Xinchen Yuan, Chicheng Jin, Yiping Zuo, Yuanchao Li
arXiv:2602. 11177v2 Announce Type: replace-cross Abstract: Reliable early detection of Alzheimer's disease (AD) is challenging, particularly due to the limited availability of labeled data.
By Lei Jiang, Yue Zhou, Natalie Parde
The study investigates whether acoustic factors encoded in pretrained self‑supervised learning (SSL) models can systematically influence predictions in speech‑based Alzheimer's disease (AD) assessment. Using the ADReSSo dataset and three large SSL backbones, the authors applied controlled noise and reverberation interventions to various audio segments and combined layer‑wise decoding, input‑ and representation‑space interventions, and geometric alignment analysis. The results demonstrate that such acoustic interventions alter AD predictions across all models, with noise producing the strongest effect, and that these effects are structured relative to the classifier’s decision direction and reproducible on a held‑out test set.
By Serli Kopar, Alkis Koudounas, Roshan P. Rane, Sam Gijsen, Paula A. Perez-Toro, Kerstin Ritter
The study explores acoustic biomarkers derived from spontaneous speech to differentiate Alzheimer's disease patients from healthy controls. Using a structured picture‑description task, low‑level prosodic, spectral, and temporal features were extracted and fed into various machine learning classifiers. The best models achieved clinically meaningful separation between diagnostic groups, indicating that non‑invasive audio screening could aid early detection of dementia.
By Anh L Tran, Arjee Javellana Restar, Bereket Kindo
arXiv:2607. 10168v1 Announce Type: cross Abstract: It is still hard to find Alzheimer's disease (AD) early, especially when neuroimaging is expensive or tools that depend on language are not available.
By Rashin Gholijani Farahani, Azam Bastanfard
arXiv:2608. 07378v1 Announce Type: cross Abstract: Early diagnosis of Alzheimer's disease (AD) is critical for enabling timely interventions that may slow disease progression and improve patient outcomes.
By Xin Wang, Yingchao Huang, Yuhan Su, Shanshan Yao, Wei Peng
The development of multilingual Alzheimer's Disease Dementia (AD) detection models presents significant challenges due to the resource-intensive and time-consuming nature of language-specific model training. We propose a novel solution using cross-language training to detect AD in languages beyond those used for model training.
The paper adapts Reinforce Adjoint Matching (RAM) to generative speech enhancement, allowing a pretrained model to be post‑trained on real recordings using weak supervision such as text transcripts. RAM shifts the model’s conditional distribution toward higher‑reward outputs by generating enhanced speech on‑policy, evaluating each output with a potentially non‑differentiable reward, and analytically re‑noising the endpoint to create inputs for a reward‑guided regression objective. Experiments on real CHiME‑4 recordings show a 5.08‑percentage‑point reduction in word error rate compared to the pretrained FlowSE model, while maintaining all reported non‑intrusive speech quality metrics and receiving no significant preference in a subjective listening test.
By Julius Richter, Christoph Boeddeker, Yoshiki Masuyama, Kohei Saijo, Dominik Klement, Gordon Wichern, Jonathan Le Roux
arXiv:2603. 15988v3 Announce Type: replace-cross Abstract: Dysarthric speech quality assessment (DSQA) is critical for clinical diagnostics and inclusive speech technologies.
By Jaesung Bae, Xiuwen Zheng, Minje Kim, Chang D. Yoo, Mark Hasegawa-Johnson
arXiv:2606. 17339v1 Announce Type: new Abstract: Speech offers a uniquely informative window into health by simultaneously engaging neurological, motor, respiratory, and vocal systems.
By Sejal Bhalla, Larry Kieu, Aina Merchant, Eyal de Lara, Alex Mariakakis
The paper addresses the challenge of within-class variation in Alzheimer’s Disease (AD) detection, where individuals with the same diagnosis can show differing levels of cognitive impairment. It introduces two methods—Soft Target Distillation (SoTD) and Instance-level Re-balancing (InRe)—that estimate sample-specific AD probabilities to better capture this heterogeneity. Experiments on the ADReSS and CU-MARVEL datasets demonstrate that these scores correlate with independent cognitive assessments and enhance AD detection performance.
By Jiawen Kang, Dongrui Han, Lingwei Meng, Jingyan Zhou, Jinchao Li, Xixin Wu, Helen Meng